Nuvation Bio (NYSE:NUVB) 2025 Conference November 19, 2025 10:00 AM ET Speaker2Hi everyone. My name is Farzin Haq, one of the biotech analysts at Jefferies. It's my pleasure to introduce David Hung, CEO, and Philippe Sauvage, CFO of Nuvation Bio. This is a five-step chat format. Thank you both for joining us today. For those that are new to the story, maybe start off with a one-minute overview of your program.Speaker1Nuvation Bio is a late-stage, commercial-stage company. We have two late-stage assets. One ...